Sargent Investment Group LLC Sells 236 Shares of CVS Health Co. (NYSE:CVS)

Sargent Investment Group LLC trimmed its stake in CVS Health Co. (NYSE:CVS) by 5.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,067 shares of the pharmacy operator’s stock after selling 236 shares during the period. Sargent Investment Group LLC’s holdings in CVS Health were worth $256,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of CVS. Pzena Investment Management LLC lifted its position in shares of CVS Health by 132.9% in the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock worth $764,023,000 after purchasing an additional 7,382,931 shares during the period. Capital International Investors grew its stake in shares of CVS Health by 12.5% in the 1st quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock valued at $3,024,334,000 after buying an additional 4,226,225 shares during the period. Capital World Investors increased its holdings in shares of CVS Health by 8.0% during the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after acquiring an additional 3,232,172 shares in the last quarter. Pathway Financial Advisers LLC increased its stake in CVS Health by 5,864.2% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator’s stock valued at $108,804,000 after purchasing an additional 1,701,331 shares in the last quarter. Finally, State of Michigan Retirement System increased its position in shares of CVS Health by 402.5% during the second quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock worth $118,455,000 after acquiring an additional 1,606,500 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently commented on CVS shares. Truist Financial increased their price target on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday, October 11th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday. Mizuho cut their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Barclays cut their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a research note on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $73.00.

CVS Health Trading Up 1.5 %

NYSE CVS opened at $55.11 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The stock has a 50-day moving average of $59.41 and a 200-day moving average of $58.79. The firm has a market cap of $69.35 billion, a PE ratio of 13.99, a price-to-earnings-growth ratio of 0.93 and a beta of 0.55.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the business posted $2.21 EPS. As a group, sell-side analysts forecast that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.83%. CVS Health’s dividend payout ratio is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.